Chosa Oncology AB operates as a biotechnology company, which focuses on developing drugs related to cancer treatment. Its products include iCIP, LiPlaCis and DRP. The company was founded on January 11, 2023 and is headquartered in Lund, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company